Vimarsana
Biggest News Aggregation in the World

Page 6 - Bart De Strooper News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bart De Strooper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bart De Strooper Today - Breaking & Trending Today

Scientists discover how brain cells die in Alzheimer's: study - Vimarsana News

Scientists discover how brain cells die in Alzheimer's: study

A breakthrough in Alzheimer's research has finally answered the question scientists have been asking for years. Scientists have discovered how brain cells die when people develop Alzheimer's, a study published in Science revealed.

Source: nypost.com
Researchers discover key clue to what kills brain cells in Alzheimer's disease - Vimarsana News

Researchers discover key clue to what kills brain cells in Alzheimer's disease

A team of researchers from Britain and Belgium has connected the abnormal proteins that build up in the brain with 'necroptosis' - a form of cellular 'suicide'.

Startling Findings – New Study Indicates That Brain Hemorrhage Risk Can Be Transmitted Through Blood Transfusions - Vimarsana News

Startling Findings – New Study Indicates That Brain Hemorrhage Risk Can Be Transmitted Through Blood Transfusions

A major study published in JAMA led by experts from the Karolinska Institute indicates that spontaneous brain hemorrhage might be transferrable through blood transfusion. However, the likelihood of someone experiencing a brain hemorrhage after a blood donation is extremely low. Cerebral amyloid a

Alzheimer's Drug Donanemab Helps Most When Taken Early in Disease - Vimarsana News

Alzheimer's Drug Donanemab Helps Most When Taken Early in Disease

An Alzheimer’s drug that attacks the protein amyloid does not work as well in people with more advanced disease

BBCNEWS The Context June 4, 2024 19:50:00 - Vimarsana News

BBCNEWS The Context June 4, 2024 19:50:00

Alzheimer's patient has one. there's another hurdle. donanemab has potentially serious side effects. it can cause swelling and bleeding in the brain, so patients will need to be aware of the risks and be carefully monitored. but despite safety concerns, there will be huge demand for this new drug, which mike will continue to receive as long as it helps him. after decades of failed trials, the era of alzheimer's treatment is upon us. so important to so many families out there. we can speak now to bart de strooper, a professor in alzheimer's disease at university college london and director of u...